Vericel Corp
NASDAQ:VCEL
Vericel Corp
NASDAQ:VCEL
Price:
49.52 USD
5.5%
Market Closed
Updated:
May 8, 2024
Vericel Corp
Cash from Operating Activities
|
Vericel Corp
Cash from Operating Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vericel Corp
NASDAQ:VCEL
|
Cash from Operating Activities
$35.3m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Operating Activities
$22.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Operating Activities
$8B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Operating Activities
$8.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
2%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Operating Activities
$4.7B
|
CAGR 3-Years
22%
|
CAGR 5-Years
14%
|
CAGR 10-Years
24%
|
See Also
What is Vericel Corp's Cash from Operating Activities?
Cash from Operating Activities
35.3m
USD
35.3m
USD
Based on the financial report for Dec 31, 2023, Vericel Corp's Cash from Operating Activities amounts to 35.3m USD.
What is Vericel Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
26%
26%
Over the last year, the Cash from Operating Activities growth was 100%. The average annual Cash from Operating Activities growth rates for Vericel Corp have been 26% over the past three years .
You don't have any saved screeners yet
